Literature DB >> 33398113

Systemic viral spreading and defective host responses are associated with fatal Lassa fever in macaques.

Nicolas Baillet1,2, Stéphanie Reynard1,2, Emeline Perthame3, Jimmy Hortion1,2, Alexandra Journeaux1,2, Mathieu Mateo1,2, Xavier Carnec1,2, Justine Schaeffer1,2, Caroline Picard1,2, Laura Barrot4, Stéphane Barron4, Audrey Vallve4, Aurélie Duthey4, Frédéric Jacquot4, Cathy Boehringer4, Grégory Jouvion5, Natalia Pietrosemoli3, Rachel Legendre3, Marie-Agnès Dillies3, Richard Allan6, Catherine Legras-Lachuer6, Caroline Carbonnelle4, Hervé Raoul4, Sylvain Baize7,8.   

Abstract

pan class="Species">Lassa virus (pan class="Species">LASV) is endemic in West Africa and induces a viral hemorrhagic fever (VHF) with up to 30% lethality among clinical cases. The mechanisms involved in control of Lassa fever or, in contrast, the ensuing catastrophic illness and death are poorly understood. We used the cynomolgus monkey model to reproduce the human disease with asymptomatic to mild or fatal disease. After initial replication at the inoculation site, LASV reached the secondary lymphoid organs. LASV did not spread further in nonfatal disease and was rapidly controlled by balanced innate and T-cell responses. Systemic viral dissemination occurred during severe disease. Massive replication, a cytokine/chemokine storm, defective T-cell responses, and multiorgan failure were observed. Clinical, biological, immunological, and transcriptomic parameters resembled those observed during septic-shock syndrome, suggesting that similar pathogenesis is induced during Lassa fever. The outcome appears to be determined early, as differentially expressed genes in PBMCs were associated with fatal and non-fatal Lassa fever outcome very early after infection. These results provide a full characterization and important insights into Lassa fever pathogenesis and could help to develop early diagnostic tools.

Entities:  

Year:  2021        PMID: 33398113      PMCID: PMC7782745          DOI: 10.1038/s42003-020-01543-7

Source DB:  PubMed          Journal:  Commun Biol        ISSN: 2399-3642


  77 in total

1.  Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells.

Authors:  J M Curtsinger; C S Schmidt; A Mondino; D C Lins; R M Kedl; M K Jenkins; M F Mescher
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

2.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features.

Authors:  Yang Liao; Gordon K Smyth; Wei Shi
Journal:  Bioinformatics       Date:  2013-11-13       Impact factor: 6.937

Review 3.  Stromal cell networks coordinate immune response generation and maintenance.

Authors:  Yannick O Alexandre; Scott N Mueller
Journal:  Immunol Rev       Date:  2018-05       Impact factor: 12.988

Review 4.  Sepsis and septic shock.

Authors:  Richard S Hotchkiss; Lyle L Moldawer; Steven M Opal; Konrad Reinhart; Isaiah R Turnbull; Jean-Louis Vincent
Journal:  Nat Rev Dis Primers       Date:  2016-06-30       Impact factor: 52.329

5.  Virus-induced transient bone marrow aplasia: major role of interferon-alpha/beta during acute infection with the noncytopathic lymphocytic choriomeningitis virus.

Authors:  D Binder; J Fehr; H Hengartner; R M Zinkernagel
Journal:  J Exp Med       Date:  1997-02-03       Impact factor: 14.307

Review 6.  Exotoxins and endotoxins: Inducers of inflammatory cytokines.

Authors:  Jean-Marc Cavaillon
Journal:  Toxicon       Date:  2017-10-19       Impact factor: 3.033

7.  Early blood profiles of virus infection in a monkey model for Lassa fever.

Authors:  Mahmoud M Djavani; Oswald R Crasta; Juan Carlos Zapata; Zhangjun Fei; Otto Folkerts; Bruno Sobral; Mark Swindells; Joseph Bryant; Harry Davis; C David Pauza; Igor S Lukashevich; Rasha Hammamieh; Marti Jett; Maria S Salvato
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

8.  Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans.

Authors:  Troy D Querec; Rama S Akondy; Eva K Lee; Weiping Cao; Helder I Nakaya; Dirk Teuwen; Ali Pirani; Kim Gernert; Jiusheng Deng; Bruz Marzolf; Kathleen Kennedy; Haiyan Wu; Soumaya Bennouna; Herold Oluoch; Joseph Miller; Ricardo Z Vencio; Mark Mulligan; Alan Aderem; Rafi Ahmed; Bali Pulendran
Journal:  Nat Immunol       Date:  2008-11-23       Impact factor: 25.606

9.  Development of a new vaccine for the prevention of Lassa fever.

Authors:  Thomas W Geisbert; Steven Jones; Elizabeth A Fritz; Amy C Shurtleff; Joan B Geisbert; Ryan Liebscher; Allen Grolla; Ute Ströher; Lisa Fernando; Kathleen M Daddario; Mary C Guttieri; Bianca R Mothé; Tom Larsen; Lisa E Hensley; Peter B Jahrling; Heinz Feldmann
Journal:  PLoS Med       Date:  2005-06-28       Impact factor: 11.069

10.  A community approach to mortality prediction in sepsis via gene expression analysis.

Authors:  Timothy E Sweeney; Thanneer M Perumal; Ricardo Henao; Marshall Nichols; Judith A Howrylak; Augustine M Choi; Jesús F Bermejo-Martin; Raquel Almansa; Eduardo Tamayo; Emma E Davenport; Katie L Burnham; Charles J Hinds; Julian C Knight; Christopher W Woods; Stephen F Kingsmore; Geoffrey S Ginsburg; Hector R Wong; Grant P Parnell; Benjamin Tang; Lyle L Moldawer; Frederick E Moore; Larsson Omberg; Purvesh Khatri; Ephraim L Tsalik; Lara M Mangravite; Raymond J Langley
Journal:  Nat Commun       Date:  2018-02-15       Impact factor: 14.919

View more
  7 in total

1.  Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing.

Authors:  Alex P Salam; Alexandre Duvignaud; Marie Jaspard; Denis Malvy; Miles Carroll; Joel Tarning; Piero L Olliaro; Peter W Horby
Journal:  PLoS Negl Trop Dis       Date:  2022-03-30

2.  Special Issue "Arenaviruses 2020".

Authors:  Igor S Lukashevich; Juan Carlos de la Torre
Journal:  Viruses       Date:  2021-04-18       Impact factor: 5.048

3.  Pathogenesis of recent Lassa virus isolates from lineages II and VII in cynomolgus monkeys.

Authors:  Mathieu Mateo; Jimmy Hortion; Emeline Perthame; Caroline Picard; Stéphanie Reynard; Alexandra Journeaux; Clara Germain; Xavier Carnec; Nicolas Baillet; Virginie Borges-Cardoso; Natalia Pietrosemoli; Audrey Vallve; Stéphane Barron; Ophélie Jourjon; Orianne Lacroix; Aurélie Duthey; Manon Dirheimer; Maïlys Daniau; Catherine Legras-Lachuer; Gregory Jouvion; Caroline Carbonnelle; Hervé Raoul; Sylvain Baize
Journal:  Virulence       Date:  2022-12       Impact factor: 5.428

4.  Understanding Host-Virus Interactions: Assessment of Innate Immune Responses in Mastomys natalensis Cells after Arenavirus Infection.

Authors:  Nele Marie Brinkmann; Chris Hoffmann; Stephanie Wurr; Elisa Pallasch; Julia Hinzmann; Eleonore Ostermann; Wolfram Brune; Maria Elisabeth Eskes; Lukas Jungblut; Stephan Günther; Ludmilla Unrau; Lisa Oestereich
Journal:  Viruses       Date:  2022-09-08       Impact factor: 5.818

5.  Experimental Morogoro Virus Infection in Its Natural Host, Mastomys natalensis.

Authors:  Chris Hoffmann; Stephanie Wurr; Elisa Pallasch; Sabrina Bockholt; Toni Rieger; Stephan Günther; Lisa Oestereich
Journal:  Viruses       Date:  2021-05-07       Impact factor: 5.048

Review 6.  Opportunities for Refinement of Non-Human Primate Vaccine Studies.

Authors:  Mark J Prescott; Carolyn Clark; William E Dowling; Amy C Shurtleff
Journal:  Vaccines (Basel)       Date:  2021-03-19

7.  Infection of Human Endothelial Cells with Lassa Virus Induces Early but Transient Activation and Low Type I IFN Response Compared to the Closely-Related Nonpathogenic Mopeia Virus.

Authors:  Othmann Merabet; Natalia Pietrosemoli; Emeline Perthame; Jean Armengaud; Jean-Charles Gaillard; Virginie Borges-Cardoso; Maïlys Daniau; Catherine Legras-Lachuer; Xavier Carnec; Sylvain Baize
Journal:  Viruses       Date:  2022-03-21       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.